Avalon GloboCare Corp
AVCO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.26M
Close$
Share Statistics
| Market cap | $5.26 Million |
|---|---|
| Enterprise Value | $4.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.64 |
| Beta | 0.81 |
| Outstanding Shares | 8,963,998 |
Return
| Return on Equity | -165.59% |
|---|---|
| Return on Assets | -119.50% |
| Return on Invested Capital | -196.77% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | -0.21 |
| Price to Sales | - |
| Price to Book Ratio | 0.53 |
| Enterprise Value to Revenue | 6.63 |
| Enterprise Value to EBIT | -0.2 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Avalon GloboCare Corp
7 employeesAvalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 rela...